Babraham Research Campus的动态

Kind reminder for the coming webinar, presented by Dr. John Dulos, a renowned translational science expert and co-inventor of anti-PD1 pembrolizumab (Keytruda). Don't miss his talk 'Turning Setbacks into Success: Translational Science in Action'.

"How to design a specific primer for your study?? " Searching for a solution? ?? Here it is.. "PRIMERPRO" A hands on training program on primer designing handled by exerts in the field. Limited seats available... Hurry up & grab the oppurtunity!!!

Early bird rates end June 3 for BioCentury Grand Rounds – an R&D conference in Nashville for academic innovators, researchers, investors and industry leaders to explore?the translational science behind?the next wave of biotech breakthroughs and the people driving them. Take advantage of these special rates and make connections with peers across the biopharma sphere as we discuss: ? What Investors Want: Gain insights from top investors on what they’re looking for in today’s market. ? ? New Investible Space: Discover emerging sectors and opportunities that are catching the eye of investors. ? ? Measurements of Translational Success: Learn how to measure and showcase the impact of your innovations. Register now to secure your spot at #BioCenturyGrandRounds: https://loom.ly/yydzbC8 Submit your nominations to join the Presenting Companies Class of 2024 by June 3 to lock in early bird rates: https://loom.ly/GHHuDog #GrandRounds #BiotechBreakthroughs #researchdevelopment #academia #venturecapital #biotech #drugdiscovery #drugdevelopment #RnD

We are thrilled to announce a new strategic partnership with Eurobio Scientific, a leading provider of in-vitro diagnostics and life science solutions. Eurobio Scientific will serve as Gelomics' exclusive distributor in France, enabling us to bring our cutting-edge 3D tissue culture technologies closer to French researchers and institutions. This collaboration is a significant milestone in our mission to revolutionise drug development and biomedical research by providing ethical, predictive, and cost-effective alternatives to traditional methods. Together with Eurobio Scientific, we aim to accelerate therapeutic breakthroughs and drive progress in the life sciences community. #LifeSciences #3DCellCulture #DrugDevelopment #Partnership #Innovation Christoph Meinert, PhD Peter Levett Celia Sid-Otmane KAHINA ABBAS Yannick Lepage

#Deliberate #angel #investing is about more than just funding—it’s about empowering visionary #entrepreneurs to invent the future. By backing not just ideas but entrepreneurs with the drive to revolutionize industries, we’re paving the way for more human-relevant, ethical breakthroughs. #3DCellCulture #Innovation #Partnership #AngelInvesting Christoph Meinert, PhD Pawel Mieszczanek AngelLoop

Thrilled to share that I recently attended a workshop on Software MzDOCK for Molecular Docking hosted by BMS Group!?? Molecular docking is a crucial technique in modern drug design, enabling researchers to predict the binding interactions between molecules.?? This training has deepened my understanding of molecular docking principles and its applications in drug discovery. I'm excited to leverage these new skills to explore potential drug candidates and contribute to innovative research in the field of life sciences.?? #moleculardocking #MzDOCK #research #drugdiscovery #therapeutics.

?? 2024 has come to an end, and what a fruitful year it was for PredictCan Biotechnologies !?? This year, we achieved significant milestones: ?? 2 scientific publications ??2 posters presented at EUROTOX Congress 2024 ??1 patent filed ??Several new collaborations, including partnerships with PARIS CHU, Centre Léon Bérard, Réseau des CRB Foie, and more exciting announcements coming soon. ? Looking ahead, 2025 promises to be even better for PredictCan Biotechnologies! ??We are committed to advancing our cell education technology with new scientific publications—??one of which will be announced very soon. ??We are also expanding our international collaborations to promote broader adoption of alternative methods to animal testing and pave the way for personalized medicine. ??Stay tuned for more updates as we continue this exciting journey! #predictcan #newyear #innovation #educationtechnology #2025

?? Industry News: "AGRF Expands #Olink? Platform with Signature Q100, Boosting Biomarker Discovery and Prognosis Capabilities" ?? Exciting opportunities as we announce the expansion of our Olink? fleet with the addition of the Olink Signature Q100 platform. This new addition complements our existing Olink Explore HT and Explore 3072 workflows, further strengthening the capabilities in providing comprehensive proteomic analyses. All made possible through a valuable partnership with The Kids Research Institute Australia (The Kids) in Perth, which funded the platform. This new service, operated by AGRF opens up exciting opportunities for researchers across multiple disciplines. ?? A heartfelt thank you to everyone involved in this wonderful collaboration. ?? The Kids Research Institute Australia ?? Samuel Montgomery, Research Officer, The Kids ?? Desley Pitcher, Head of Sales, AGRF ?? Dr Benjamin Cooper, Technical Officer, AGRF ?? Dr Dhanya Sooraj, Senior Scientist (Applied Genomics), AGRF ?? Matthew Andrews, Bioinformatician, AGRF ?? Kelsey Maloney, Laboratory Automation Specialist, AGRF ?? Learn more here: https://lnkd.in/gm72SxRY ? Have questions? Email our team directly ?? [email protected] #AGRF #Proteomics #Olink #TheKids #CuttingEdgeResearch #WorldClassServices #BiomarkerDiscovery #ResearchExcellence #ClinicalResearch #DrugDevelopment #Biotechnology #ProteomicsExperts #InnovativeScience #ScientificCollaboration #NextGenScience #PrecisionMedicine #TeamAGRF

This summer, members will start moving into the latest addition to our science park – a state-of-the-art laboratory building for advanced research and medical development. Our brand-new laboratory building strengthens our position as the largest value-driven life science park in Scandinavia, enabling us to accommodate more companies eager to make a difference. ? Through this investment in 12,500 square metres spread across four floors, the conditions for the continued expansion of our life science park and the life science community in our innovation district are strengthened for the coming years. The new laboratory facility is estimated to host 7 to 8 companies and 300 to 350 workspaces when it is fully operational. ? The building will provide opportunities for existing members of our science park to expand. At the same time, the space they leave will open up for new members to establish themselves here and grow. ? The first company to move into the new laboratory building is Medicon Village member Truly Labs, which offers contract research in drug development with a focus on translational research, i.e., the transition from pre-clinical to clinical activities. They will then be joined by four other fast-growing member companies: Alligator Bioscience, Cellevate, Redoxis, SARomics Biostructures. ? Link for details in the comment section below. ? #laboratory #research #innovation #lifescience #sciencepark Alligator Bioscience AB | Cellevate AB | Redoxis AB | SARomics Biostructures AB | Truly Labs

Beyond SBIRs: Non-Dilutive Funding Strategies to Advance Your Pipeline and Bottom-Line Explore how federal partnerships can fuel your biotech growth without relying on grant submissions. Join biotech leaders and federal lab experts as they share strategies to secure non-dilutive support, achieve value inflection points, and manage burn rates. Panelists: ?? Michael Salgaller, The National Institutes of Health Technology Transfer Office (Moderator) ?? Deborah Birx, George W. Bush Presidential Center ?? Vladimir Popov, PhD, MBA, Frederick National Laboratory for Cancer Research & Federal Lab Consortium ?? J. Jill Hopkins, MD, Aura Biosciences ?? Erica Stone, GigaGen Inc ?? Xiaoxi (Sofie) Wei, X-Therma Inc. ?? Don’t miss this interactive panel at RESI JPM: https://lnkd.in/eMWxaEeu #RESIJPM #BiotechFunding #LifeSciences #NonDilutiveFunding #BiotechInnovation